Relationship between type-2 diabetes and use of metformin with risk of colorectal adenoma in an American population receiving colonoscopy

Journal of Diabetes and its Complications

Volumn 27, Issue 5, 2013, Pages 463-466

  Kanadiya, Mehulkumar K ^a   Gohel, Tushar D ^b   Sanaka, Madhusudhan R ^b   Thota, Prashanthi N ^b   Shubrook, Jay H ^a  

^a OHIO UNIVERSITY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Colorectal adenoma; Colorectal cancer; Metformin; Type 2 diabetes

Indexed keywords

METFORMIN;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER MORPHOLOGY; CANCER RISK; COLONOSCOPY; COLORECTAL ADENOMA; CONTROLLED STUDY; DIABETIC PATIENT; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFECT; FEMALE; HEALTH CARE PERSONNEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; POPULATION RESEARCH; PRIORITY JOURNAL; TUMOR VOLUME; WESTERN HEMISPHERE;

COLORECTAL ADENOMA; COLORECTAL CANCER; METFORMIN; TYPE-2 DIABETES;

ADENOMA; AGED; COLONOSCOPY; COLORECTAL NEOPLASMS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; METFORMIN; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES;

EID: 84883772893     PISSN: 10568727     EISSN: 1873460X     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2013.04.010     Document Type: Article

References (26)

1. C. Algire, L. Amrein, M. Zakikhani, L. Panasci, and M. Pollak Metformin blocks the stimulative effect of a high-energy diet on colon carcinoma growth in vivo and is associated with reduced expression of fatty acid synthase Endocrine-Related Cancer 17 2 2010 351 360
2. J.M. Berster, and B. Goke Type 2 diabetes mellitus as risk factor for colorectal cancer Archives of Physiology and Biochemistry 114 1 2008 84 98
3. W.R. Bruce, T.M. Wolever, and A. Giacca Mechanisms linking diet and colorectal cancer: The possible role of insulin resistance Nutrition and Cancer 37 1 2000 19 26
4. Buzzai, M. (2007). Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor, cell growth.67(14), 6745-6752.
5. Centers for Disease Control and Prevention (CDC) National diabetes fact sheet: National estimates and general information on diabetes and prediabetes in the United States, 2011. Atlanta, GA: U.S Available at http://www.cdc.gov/ diabetes/pubs/pdf/ndfs-2011.pdf 2011 Accessed 8 October 2012
6. Centers for Disease Control and Prevention (CDC) Available at http://www.cdc.gov/cancer/colorectal/statistics/index.htmhttp://www.cdc.gov/ cancer/colorectal/statistics/index.htm 2011 Accessed 8 October 2012
7. Y.W. Chung, D.S. Han, K.H. Park, C.S. Eun, K.S. Yoo, and C.K. Park Insulin therapy and colorectal adenoma risk among patients with type 2 diabetes mellitus: A case-control study in Korea Diseases of the Colon and Rectum 51 5 2008 593 597
8. F. Citarda, G. Tomaselli, R. Capocaccia, S. Barcherini, M. Crespi Italian Multicenter Study Group Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence. Gut 48 6 2001 812 815
9. J.E. Elwing, F. Gao, N.O. Davidson, and D.S. Early Type 2 diabetes mellitus: The impact on colorectal adenoma risk in women The American Journal of Gastroenterology 101 8 2006 1866 1871
10. C.R. Garrett, H.M. Hassabo, N.A. Bhadkamkar, S. Wen, V. Baladandayuthapani, and B.K. Kee Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer British Journal of Cancer 106 8 2012 1374 1378
11. O. Giouleme, M.D. Diamantidis, and M.G. Katsaros Is diabetes a causal agent for colorectal cancer? Pathophysiological and molecular mechanisms World Journal of Gastroenterology: WJG 17 4 2011 444 448
12. T. Jin Why diabetes patients are more prone to the development of colon cancer? Medical Hypotheses 71 2 2008 241 244
13. H.U. Kramer, H. Muller, C. Stegmaier, D. Rothenbacher, E. Raum, and H. Brenner Type 2 diabetes mellitus and gender-specific risk for colorectal neoplasia European Journal of Epidemiology 27 5 2012 341 347
14. J.H. Lee, T.I. Kim, S.M. Jeon, S.P. Hong, J.H. Cheon, and W.H. Kim The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus International Journal of Cancer. Journal International Du Cancer 131 3 2012 752 759
15. M. Lee, C. Hsu, M. Wahlqvist, H. Tsai, Y. Chang, and Y. Huang Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: A representative population prospective cohort study of 800,000 individuals BMC Cancer 11 1 2011 20
16. Libby, G., Donnelly, L. A., Donnan, P. T., Alessi, D. R., Morris, A. D., & Evans, J. M. (2009). New users of metformin are at low risk of incident cancer: A cohort study among people with type 2 diabetes.32(9), 1620-1625.
17. T. Marugame, K. Lee, H. Eguchi, T. Oda, K. Shinchi, and S. Kono Relation of impaired glucose tolerance and diabetes mellitus to colorectal adenomas in Japan Cancer Causes & Control 13 10 2002 917 921
18. A.D. Muller, and A. Sonnenberg Prevention of colorectal cancer by flexible endoscopy and polypectomy. A case control study of 32,702 veterans Annals of Internal Medicine 123 12 1995 904 910
19. M.N. Pollak Investigating metformin for cancer prevention and treatment: The end of the beginning Cancer Discovery 2 9 2012 1 3
20. D.K. Rex, J.H. Bond, S. Winawer, T.R. Levin, R.W. Burt, and D.A. Johnson Quality in the technical performance of colonoscopy and the continuous quality improvement process for colonoscopy: Recommendations of the U.S. multi-society task force on colorectal cancer The American Journal of Gastroenterology 97 6 2002 1296 1308
21. C.J. Smith, G.A. McKay, and M. Fisher Diabetes, colorectal cancer and cyclooxygenase 2 inhibition International Journal of Clinical Practice 62 5 2008 810 815
22. B. Viollet, B. Guigas, N. Sanz Garcia, J. Leclerc, M. Foretz, and F. Andreelli Cellular and molecular mechanisms of metformin: An overview Clinical Science (London, England) 122 6 2012 253 270
23. H.S. Wang, J. Pisegna, R. Modi, L. Liang, M. Atia, and M. Nguyen Adenoma detection rate is necessary but insufficient for distinguishing high versus low endoscopist performance Gastrointestinal Endoscopy 77 1 2013 71 78
24. S.J. Winawer, A.G. Zauber, and M.N. Ho Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study workgroup The New England Journal of Medicine 329 1993 1977 1981
25. M. Zakikhani, R.J. Dowling, N. Sonenberg, and M.N. Pollak The effects of adiponectin and metformin on prostate and colon neoplasia involve activation of AMP-activated protein kinase Cancer 1 5 2008 369 375
26. Z.J. Zhang, Z.J. Zheng, H. Kan, Y. Song, W. Cui, and G. Zhao Reduced risk of colorectal cancer with metformin therapy in patients with type 2 diabetes: A meta-analysis Diabetes Care 34 10 2011 2323 2328